Literature DB >> 6217184

Clinical evaluation of moxalactam therapy.

F R Venezio, G O Westenfelder, F V Cook, J E Williams, M Carruthers, B E Reisberg, J Emmerman, J P Phair.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6217184     DOI： 10.1093/jac/10.5.435

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

Review 1.  Is it reasonable to use cephalosporins in respiratory and upper tract renal infections in hospitalized patients?

Authors:  R L Perkins
Journal:  Bull N Y Acad Med       Date:  1984-05

Review 2.  Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; J A Romankiewicz; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-10       Impact factor: 9.546

3.  Use of ceftazidime in the therapy of serious infections, including those due to multiresistant organisms.

Authors:  N Clumeck; Y Van Laethem; B Gordts; N Jaspar; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.